Historique de carrière de Jennifer Creel
Anciens postes connus de Jennifer Creel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADC THERAPEUTICS SA | Director of Finance/CFO | 20/05/2020 | 19/12/2022 |
| CELGENE | Corporate Officer/Principal | 01/01/2008 | 01/01/2020 |
Formation de Jennifer Creel
| The College of William & Mary | Undergraduate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| Suisse | 2 |
Opérationnelle
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADC THERAPEUTICS SA | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bourse
- Insiders
- Jennifer Creel
- Expérience
